Biosyntech (Biosyntech) Market Cap

: $0.00 Mil (As of Today)

View and export this data going back to 2000. Start your Free Trial

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Biosyntech's share price for the quarter that ended in Dec. 2009 was $0.11. Biosyntech's Shares Outstanding (EOP) for the quarter that ended in Dec. 2009 was 114.52 Mil. Therefore, Biosyntech's market cap for the quarter that ended in Dec. 2009 was $12.60 Mil.

Biosyntech's quarterly market cap increased from Jun. 2009 ($10.54 Mil) to Sep. 2009 ($11.60 Mil) and increased from Sep. 2009 ($11.60 Mil) to Dec. 2009 ($12.60 Mil).

Biosyntech's annual market cap declined from Mar. 2007 ($41.06 Mil) to Mar. 2008 ($23.87 Mil) and declined from Mar. 2008 ($23.87 Mil) to Mar. 2009 ($13.71 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Biosyntech's Enterprise Value for Today is $0.00 Mil.

Biosyntech Market Cap Historical Data

The historical data trend for Biosyntech's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyntech Annual Data

Trend

Mar00

Mar01

Mar02

Mar03

Mar04

Mar05

Mar06

Mar07

Mar08

Mar09

Market Cap

19.22

38.16

41.06

23.87

13.71

Biosyntech Quarterly Data
	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09
Market Cap																4.80	13.71	10.54	11.60	12.60

Competitive Comparison

For the Biotechnology subindustry, Biosyntech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biosyntech Market Cap Distribution

For the Biotechnology industry and Healthcare sector, Biosyntech's Market Cap distribution charts can be found below:

* The bar in red indicates where Biosyntech's Market Cap falls into.

Biosyntech Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Biosyntech's Market Cap for the fiscal year that ended in Mar. 2009 is calculated as

Market Cap (A: Mar. 2009 )	=	Share Price (A: Mar. 2009 )	*	Shares Outstanding (EOP) (A: Mar. 2009 )
	=	$0.13	*	105.442
	=	$13.71

Biosyntech's Market Cap for the quarter that ended in Dec. 2009 is calculated as

Market Cap (Q: Dec. 2009 )	=	Share Price (Q: Dec. 2009 )	*	Shares Outstanding (EOP) (Q: Dec. 2009 )
	=	$0.11	*	114.516
	=	$12.60

Biosyntech (OTCPK:BSYI) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Biosyntech Market Cap Related Terms

Thank you for viewing the detailed overview of Biosyntech's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosyntech (Biosyntech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosyntech Inc (OTCPK:BSYI) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3

Website

http://www.biosyntech.com

Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.

Biosyntech (Biosyntech) Headlines

No Headlines